Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection

Completed · Phase 4

Conditions studied: Staphylococcus Aureus

In brief

The purpose of this study is to compare the outcome of treatment for bacteremic MRSA infection with vancomycin alone, vancomycin plus gentamicin, vancomycin plus rifampin, and vancomycin plus gentamicin and rifampin.

Key facts

Study ID

NCT00304811

Run by

Michael E. DeBakey VA Medical Center

People needed

160

Starts

2006-01-01

Expected to finish

2007-01-01

Last updated by the study team

2009-09-28

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with MRSA in a blood culture processed as standard of care at the VAMC
• Patients or next of kin willing to sign consent to be randomized by social security number to one of the treatments.

You may not qualify if…

• none

Where it is running

• Baylor College of Medicine — Houston, Texas, United States
• Michael E. DeBakey Veterans Affairs Medical Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.